Literature DB >> 24214181

Osteopontin binding to lipopolysaccharide lowers tumor necrosis factor-α and prevents early alcohol-induced liver injury in mice.

Xiaodong Ge1, Tung-Ming Leung, Elena Arriazu, Yongke Lu, Raquel Urtasun, Brian Christensen, Maria Isabel Fiel, Satoshi Mochida, Esben S Sørensen, Natalia Nieto.   

Abstract

UNLABELLED: Although osteopontin (OPN) is induced in alcoholic patients, its role in the pathophysiology of alcoholic liver disease (ALD) remains unclear. Increased translocation of lipopolysaccharide (LPS) from the gut is key for the onset of ALD because it promotes macrophage infiltration and activation, tumor necrosis factor-α (TNFα) production, and liver injury. Since OPN is protective for the intestinal mucosa, we postulated that enhancing OPN expression in the liver and consequently in the blood and/or in the gut could protect from early alcohol-induced liver injury. Wild-type (WT), OPN knockout (Opn(-/-)), and transgenic mice overexpressing OPN in hepatocytes (Opn(HEP) Tg) were fed either the control or the ethanol Lieber-DeCarli diet. Ethanol increased hepatic, plasma, biliary, and fecal OPN more in Opn(HEP) Tg than in WT mice. Steatosis was less in ethanol-treated Opn(HEP) Tg mice as shown by decreased liver-to-body weight ratio, hepatic triglycerides, the steatosis score, oil red-O staining, and lipid peroxidation. There was also less inflammation and liver injury as demonstrated by lower alanine aminotransferase (ALT) activity, hepatocyte ballooning degeneration, LPS levels, the inflammation score, and the number of macrophages and TNFα(+) cells. To establish if OPN could limit LPS availability and its noxious effects in the liver, binding studies were performed. OPN showed binding affinity for LPS which prevented macrophage activation, reactive oxygen, and nitrogen species generation and TNFα production. Treatment with milk OPN (m-OPN) blocked LPS translocation in vivo and protected from early alcohol-induced liver injury.
CONCLUSION: Natural induction plus forced overexpression of OPN in the liver or treatment with m-OPN protect from early alcohol-induced liver injury by blocking the gut-derived LPS and TNFα effects in the liver.
© 2014 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24214181      PMCID: PMC3966944          DOI: 10.1002/hep.26931

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  30 in total

1.  Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity.

Authors:  S Ashkar; G F Weber; V Panoutsakopoulou; M E Sanchirico; M Jansson; S Zawaideh; S R Rittling; D T Denhardt; M J Glimcher; H Cantor
Journal:  Science       Date:  2000-02-04       Impact factor: 47.728

2.  Scavenger receptor A (SR-A) is required for LPS-induced TLR4 mediated NF-κB activation in macrophages.

Authors:  Honghui Yu; Tuanzhu Ha; Li Liu; Xiaohui Wang; Ming Gao; Jim Kelley; Race Kao; David Williams; Chuanfu Li
Journal:  Biochim Biophys Acta       Date:  2012-05-14

Review 3.  Redox regulation of cytokine expression in Kupffer cells.

Authors:  Hidekazu Tsukamoto
Journal:  Antioxid Redox Signal       Date:  2002-10       Impact factor: 8.401

4.  Kupffer cell sensitization by alcohol involves increased permeability to gut-derived endotoxin.

Authors:  N Enomoto; K Ikejima; S Yamashina; M Hirose; H Shimizu; T Kitamura; Y Takei; N Sato And; R G Thurman
Journal:  Alcohol Clin Exp Res       Date:  2001-06       Impact factor: 3.455

5.  Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease.

Authors:  Derrick E Fouts; Manolito Torralba; Karen E Nelson; David A Brenner; Bernd Schnabl
Journal:  J Hepatol       Date:  2012-02-09       Impact factor: 25.083

6.  Thalidomide prevents alcoholic liver injury in rats through suppression of Kupffer cell sensitization and TNF-alpha production.

Authors:  Nobuyuki Enomoto; Yoshiyuki Takei; Miyoko Hirose; Kenichi Ikejima; Hiroto Miwa; Tsuneo Kitamura; Nobuhiro Sato
Journal:  Gastroenterology       Date:  2002-07       Impact factor: 22.682

7.  Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis.

Authors:  Oriol Morales-Ibanez; Marlene Domínguez; Sung H Ki; Miguel Marcos; Javier F Chaves; Eric Nguyen-Khac; Hakim Houchi; Silvia Affò; Pau Sancho-Bru; José Altamirano; Javier Michelena; Juan Carlos García-Pagán; Juan G Abraldes; Vicente Arroyo; Juan Caballería; Francisco-Javier Laso; Bin Gao; Ramón Bataller
Journal:  Hepatology       Date:  2013-08-19       Impact factor: 17.425

8.  Milk osteopontin, a nutritional approach to prevent alcohol-induced liver injury.

Authors:  Xiaodong Ge; Yongke Lu; Tung-Ming Leung; Esben S Sørensen; Natalia Nieto
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-03-21       Impact factor: 4.052

9.  Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.

Authors:  Atul Sahai; Padmini Malladi; Hector Melin-Aldana; Richard M Green; Peter F Whitington
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-03-25       Impact factor: 4.052

10.  Transgenic mice expressing osteopontin in hepatocytes as a model of autoimmune hepatitis.

Authors:  Satoshi Mochida; Takayuki Yoshimoto; Sumie Mimura; Mie Inao; Atsushi Matsui; Akihiko Ohno; HeaSaeng Koh; Eiko Saitoh; Sumiko Nagoshi; Kenji Fujiwara
Journal:  Biochem Biophys Res Commun       Date:  2004-04-23       Impact factor: 3.575

View more
  33 in total

1.  Invariant natural killer T cells contribute to chronic-plus-binge ethanol-mediated liver injury by promoting hepatic neutrophil infiltration.

Authors:  Stephanie Mathews; Dechun Feng; Igor Maricic; Cynthia Ju; Vipin Kumar; Bin Gao
Journal:  Cell Mol Immunol       Date:  2015-02-09       Impact factor: 11.530

2.  Treatment response in the PIVENS trial is associated with decreased Hedgehog pathway activity.

Authors:  Cynthia D Guy; Ayako Suzuki; Manal F Abdelmalek; James L Burchette; Anna Mae Diehl
Journal:  Hepatology       Date:  2014-08-25       Impact factor: 17.425

3.  Regulation of Cellular Senescence by miR-34a in Alcoholic Liver Injury.

Authors:  Ying Wan; Kelly McDaniel; Nan Wu; Sugeily Ramos-Lorenzo; Trenton Glaser; Julie Venter; Heather Francis; Lindsey Kennedy; Keisaku Sato; Tianhao Zhou; Konstantina Kyritsi; Qiaobing Huang; Tami Annable; Chaodong Wu; Shannon Glaser; Gianfranco Alpini; Fanyin Meng
Journal:  Am J Pathol       Date:  2017-11-08       Impact factor: 4.307

4.  Quercetin prevents alcohol-induced liver injury through targeting of PI3K/Akt/nuclear factor-κB and STAT3 signaling pathway.

Authors:  Minglin Zhu; Xuefeng Zhou; Jinping Zhao
Journal:  Exp Ther Med       Date:  2017-10-18       Impact factor: 2.447

Review 5.  New advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseases.

Authors:  Jessica A Williams; Sharon Manley; Wen-Xing Ding
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 6.  Alcoholic hepatitis: current management.

Authors:  Erin K J Spengler; Jeffrey Dunkelberg; Ron Schey
Journal:  Dig Dis Sci       Date:  2014-05-06       Impact factor: 3.199

7.  Osteopontin deficiency does not prevent but promotes alcoholic neutrophilic hepatitis in mice.

Authors:  Raul Lazaro; Raymond Wu; Sunyoung Lee; Nian-Ling Zhu; Chia-Lin Chen; Samuel W French; Jun Xu; Keigo Machida; Hidekazu Tsukamoto
Journal:  Hepatology       Date:  2014-11-25       Impact factor: 17.425

8.  Expression and purification of non-tagged recombinant mouse SPP1 in E. coli and its biological significance.

Authors:  Shunyan Weng; Liang Zhou; Lei Han; Yunsheng Yuan
Journal:  Bioengineered       Date:  2014-10-30       Impact factor: 3.269

9.  Alcoholic hepatitis: The pivotal role of Kupffer cells.

Authors:  Duminda B Suraweera; Ashley N Weeratunga; Robert W Hu; Stephen J Pandol; Richard Hu
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

10.  Differential contribution of complement receptor C5aR in myeloid and non-myeloid cells in chronic ethanol-induced liver injury in mice.

Authors:  Rebecca L McCullough; Megan R McMullen; Dola Das; Sanjoy Roychowdhury; Michael G Strainic; M Edward Medof; Laura E Nagy
Journal:  Mol Immunol       Date:  2016-06-06       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.